Welcome to a new work week, the final couple of days of July. Here is what I’m reading this morning:
- The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs (Benzinga)
- Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually (Endpoints)
- 7 medtech stories we missed this week: July 27, 2018 (Mass Device)
- What is the hardest thing about medtech IoT? (Medical Design & Outsourcing)